The latest Medicaid Pharmacy Newsletter, dated November 2025, is now available on the Medicaid website. In addition to the December 2025 check write schedule, this edition of the newsletter includes the following articles:
- Reminder: Immunizing Pharmacist Enrollment in NC Medicaid Contraceptives and NRT Protocol Reimbursement to Pharmacies
- Reminder on NC Medicaid Pharmacy Co-payment Requirements
- NC Medicaid's Participation in Centers for Medicare & Medicaid Services Cell and Gene Therapy Access Model for Sickle Cell Disease
- Discontinuation of Coverage: Xifaxan (Rifaximin)
- North Carolina to Launch First-of-its-Kind NC Medicaid Managed Care Plan for Children and Families on December 1, 2025
- Updates to Coverage for Wegovy and Zepbound for Clinical Indications Other than Weight Loss
- Immunizing Pharmacist Enrollment and Medical Claims Billing Update
Providers are encouraged to review this important information. The 2025 Medicaid Pharmacy Newsletters can be viewed here.
Also in North Carolina, effective December 7, the Electronic Funds Transfer (EFT) Attestation will be added to the reverification provider application and to full Manage Change Requests (MCRs) when active electronic funds transfer (EFT) information is present. This attestation requires a signature from the Office Administrator (OA) on the provider's record.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
